More on HYDTF
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $2.32 |
|
|||
| Open | $2.34 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $2.34 | ||||
| Day Low | $2.30 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 31,000 | ||||
- Hydreight Technologies Announces Timing of Q2 2026 Financial Results and Investor Webcast Featuring Live Analyst Q&A
- Hydreight to Participate in Canaccord Genuity's 46th Annual Growth Conference in Boston
- Hydreight Provides Business Update on its Peptide Healthcare Platform Following Recent FDA Advisory Committee Recommendations
- Hydreight Announces Refiling of Interim Financial Statements
- Hydreight Delivers Record First Quarter 2026 Revenue of $24.9 Million with 449% Revenue Growth, $3.3 Million in Adjusted EBITDA² and $32.0 Million in Working Capital
- Hydreight Technologies Announces Timing of Q1 2026 Financial Results and Investor Webcast
- Hydreight Reports Record Fiscal 2025 Results as VSDHOne Drives Rapid Growth and Platform Scale
- Hydreight Announces Normal Course Issuer Bid
- Form D Hydreight Technologies
- Victory Square Technologies Reports Q3 2025 Financial Results & Provides Corporate Update
Entities mentioned with HYDTF
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- FDA | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Maxim Group | View Related Stories »
- Canaccord Genuity | View Related Stories »
- Show More...
